Skip to main content

Table 1 Gathering involved studies data and patient characteristics as well as adverse events

From: Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis

 

Number of cases with adverse event

Percent %

Thrombotic thrombocytopenic purpura (TTP/VITT)

237

51.5%

Acute myocardial infarction (acute MI)

2

.4%

Myocarditis

22

5%

Idiopathic thrombocytopenic purpura (ITP)

4

.8%

Intracranial hemorrhage (ICH)

33

7%

Disseminated intravascular coagulopathy (DIC)

5

1%

Guillian-Barre Syndrome (GBS)

20

4%

Acute transverse myelitis (ATM)

9

2%

Acute disseminated poly radiculopathy (ADPR)

2

.4%

Miller Fisher syndrome (MFS)

1

.2%

Acute disseminated encephalomyelitis (ADEM)

2

.4%

Inflammatory myositis

3

.6%

Renal complications

41

9%

Erythema nodosum (EN)

1

.2%

Sarcoid reaction

1

.2%

Cutaneous vasculitis

1

.2%

Steven Johnson syndrome (SJS)

1

.2%

Uveitis

1

.2%